#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Early and long-term outcomes of coronary artery bypass surgery with and without use of heart-lung machine and with special respect to renal function - A retrospective study


Authors: Julia Merkle aff001;  Jaison Sunny aff001;  Laura Ehlscheid aff001;  Anton Sabashnikov aff001;  Carolyn Weber aff001;  Kaveh Eghbalzadeh aff001;  Ilija Djordjevic aff001;  Oliver Liakopoulos aff001;  Yeong-Hoon Choi aff001;  Thorsten Wahlers aff001;  Mohamed Zeriouh aff001
Authors place of work: Department of Cardiothoracic Surgery, University Hospital of Cologne, Cologne, Germany aff001
Published in the journal: PLoS ONE 14(10)
Category: Research Article
doi: https://doi.org/10.1371/journal.pone.0223806

Summary

The aim of our study was to compare early and long-term outcome of patients undergoing either on-pump or off-pump coronary artery bypass grafting with special focus on impairment of renal function. Five hundred ninety-three consecutive patients undergoing coronary artery bypass grafting were retrospectively analyzed. They were assigned either to on-pump (n = 281) or to off-pump (n = 312) group. Early and long-term outcomes were analyzed with special focus on renal function. Basic demographics and preoperative characteristics did not differ between groups (p>0.05) as well as postoperative renal parameters (p>0.05). Postoperative odds ratios (OR) of off-pump group in comparison to on-pump group were higher without reaching significance in terms of incidence of gastrointestinal complications and pneumonia (OR = 2.23 and 1.61, respectively) as well as hazard ratios (HR) on long-term follow-up for mortality and incidence of myocardial infarction (HR = 1.50 and 2.29, respectively). Kaplan-Meier estimation analysis also revealed similar results for both groups in terms of mid- and long-term survival (Breslow p = 0.062 and Log-Rank p = 0.064, respectively) and for incidence of myocardial infarction (Breslow p = 0.102 and Log-Rank p = 0.103, respectively). Our study suggests that use or not use of coronary artery bypass did not influence postoperative renal function. Odds of early outcomes were similar in both groups as well as incidence of myocardial infarction and mortality in long-term follow-up.

Keywords:

Surgical and invasive medical procedures – Renal system – Creatinine – myocardial infarction – pneumonia – vascular surgery – Coronary artery bypass grafting – Cardiopulmonary bypass

Introduction

Cardiac surgery with coronary artery bypass grafting is one of the most frequently applied surgeries world-wide. Numerous studies have been performed in order to compare outcomes of coronary artery bypass grafting (CABG) without (OPCAB) and with use of heart-lung machine (HLM) [14]. The conflicting results remain a source of debate. Some studies reported favourable outcomes associated with off-pump surgery [49].

Large-scale prospective randomized trials have shown trends towards reduced early risks after off-pump surgery. However these early benefits could not be confirmed in terms of long-term follow-up [3, 10, 11]. Also, worse outcomes of off-pump in comparison to on-pump CABG surgery have been reported concerning graft patency as well as for greater need for coronary reintervention up to one year after surgery [12].

Impairment of renal failure is known to be an important risk factor for increased postoperative mortality of patients after on-pump CABG [1315]. On-pump surgery may be associated with accelerated growth of atherosclerosis plaques and cardiac calcification which increases operative risk. Becoming an established and feasible technique, OPCAB studies provided a greater benefit in patients with risk for development of renal failure after surgery [16, 17]. It is also known that renal failure can lead to advanced atherosclerotic burden due to changes in calcium metabolism. OPCAB may be a better alternative because of decreased blood loss, and shorter hospital stay [1, 18]. Previously published studies comparing the effect of off-pump versus on-pump CABG on clinical end-points with respect to renal impairment have yielded conflicting results [9, 19, 20].

Therefore, to shed further light on this issue, we performed a retrospective analysis to compare early and long-term outcomes of patients undergoing either on-pump or off-pump coronary artery revascularization with special focus on renal impairment.

Materials and methods

Patients (n = 593) with coronary artery disease were scheduled to undergo coronary artery bypass grafting from January 2009 to October 2012 in our institution and were retrospectively analyzed. Exclusion criteria were as follows: associated valve surgery procedures, supra-aortic vessel diseases and contraindications to aortic cross-clamping. Decisions about the type of treatment were taken according to local practices and patients were assigned to off-pump or to on-pump surgery group. Three hundred and twelve patients received off-pump and 281 patients underwent on-pump surgery.

This study has been carried out in accordance with the Declaration of Helsinki. The study design was a retrospective review of collected registry data. The Ethics Committee waived both the need for ethics approval and informed consent from patients.CABG technique has been previously described [21]. Off-pump surgery was defined as coronary artery bypass grafting (CABG) without use of heart-lung machine (OPCAB) and on-pump surgery was defined as CABG with use of heart-lung machine.

Statistical analysis

Statistic was performed using Student’s t-Test or Mann-Whitney-U Test depending if continuous variables are normally distributed or not and Chi-Square Test was applied for categorical variables. Fisher’s exact Test was performed when the minimum expected count of cells was <5. Univariate regression analysis [Odds ratio (OR)] and Cox regression analysis [Hazard Ratio (HR)] were performed to address predictors for early and long-term outcomes. Kaplan-Meier survival estimation analysis was used to address mid- and long-term survival. A p-value <0.05 was considered significant. All statistical analysis was performed using SPSS Version 25.0 (IBM Corp, Chicago, IL, USA).

Results

Basic demographics and preoperative variables did not significantly differ between both groups (p>0.05) (Table 1). Median age at surgery was 69 years in OPCAB group versus 68 years in on-pump group (p = 0.584). Also, gender, weight and urgency of surgery revealed similar results for both groups (p>0.05). In terms of number of comorbidities, incidence of diabetes, hyperlipidemia, arterial hypertension also similar results were found for both groups (p>0.05). Further, incidence of preoperative apoplexy and carotid artery stenosis did not reveal significant differences.

Tab. 1. Demographic and preoperative variables of patients undergoing coronary artery bypass surgery.
Demographic and preoperative variables of patients undergoing coronary artery bypass surgery.

Number of bypasses significantly differed between groups (p<0.001). Off-pump surgery group mostly comprised integration of one or two bypass grafts, whereas on-pump surgery group comprised three to five grafts.

Laboratory parameters were similarly distributed between both groups, such as hemoglobin (p = 0.232) and anticoagulation parameters (p = 0.269). Median of preoperative creatinine value was 0.92 (mg/dL) in OPCAB group versus 0.94 (mg/dL) in on-pump group revealing no statistical significance (p = 0.897). Also, urea did not preoperatively differ between groups (p = 0.893).

Intra- and postoperative variables of patients undergoing coronary artery bypass grafting with and without use of heart-lung machine are presented in Table 2.

Tab. 2. Intraoperative and early postoperative variables of patients undergoing coronary artery bypass surgery.
Intraoperative and early postoperative variables of patients undergoing coronary artery bypass surgery.

Cross-clamp and cardiopulmonary bypass time significantly differed between groups (p<0.001)—per definitionem—as expected due to categorization. Duration of surgery revealed significant differences between the groups (p<0.001).

ICU stay was similarly distributed between both groups as well as need for catecholamines (p = 0.251). In terms of development of complications, such as incidence of gastrointestinal complications (p = 0.478) or incidence of pneumonia (p = 0.394) no significant differences could be detected. Patients in OPCAB group stayed 12 days in hospital and patients in on-pump group 13 days.

Survival of 7-year long-term follow-up was similar between both groups (p = 0.061). Incidence of development of postoperative apoplexy and myocardial infarction was similarly distributed between the groups (p = 0.323 and p = 0.137, respectively).

In terms of postoperative laboratory renal function parameters creatinine values did not significantly differ on postoperative day 1 and day 3 (p = 0.505 and p = 0.916). Also, no significant differences were found for urea values between the groups (p = 0.809).

Odds ratios (OR) for early outcomes and hazard ratios (HR) for long-term outcomes are depicted in Table 3. Patients in OPCAB group revealed higher odds for gastrointestinal complications and pneumonia in comparison to on-pump surgery group without reaching significance (OR = 2.23 and 1.61; both p>0.05). During long-term follow-up incidence for myocardial infarction was 2.3-fold and for mortality 1.5-fold higher in OPCAB group than in on-pump group (HR = 2.29 and 1.50, respectively; both p>0.05), whereas vice versa incidence of apoplexy was 37% reduced (HR = 0.63, p>0.05). All variables did not reach significance.

Tab. 3. Odds ratios (OR) and hazard ratios (HR), 95% confidence intervals (95%-CI) and p-values of selected outcome variables of patients undergoing coronary artery bypass surgery.
Odds ratios (OR) and hazard ratios (HR), 95% confidence intervals (95%-CI) and p-values of selected outcome variables of patients undergoing coronary artery bypass surgery.

Kaplan-Meier survival estimation analysis depicts mid- (Breslow) and long-term (Log-Rank) survival for up to 7-year follow-up of patients requiring coronary artery bypass surgery with and without use of heart-lung machine revealing similar results between groups (Breslow p = 0.062; Log-Rank p = 0.064) (Fig 1) as well as for incidence of myocardial infarction (Table 4).

Fig. 1. Kaplan-Meier survival estimation plot of coronary artery bypass graft surgery with and without use of heart-lung machine (HLM).
Kaplan-Meier survival estimation plot of coronary artery bypass graft surgery with and without use of heart-lung machine (HLM).
Tab. 4. p-values of Kaplan-Meier mid-term (Breslow) and long-term (Log-Rank) estimation analysis up to 7-year follow-up.
p-values of Kaplan-Meier mid-term (Breslow) and long-term (Log-Rank) estimation analysis up to 7-year follow-up.

Discussion

Coronary artery bypass grafting is one of the most often performed surgeries world-wide with an increasing demand. Many studies revealed that use of heart-lung machine provokes inflammation leading to organ dysfunction and increased mortality [4, 22, 23].

Cardiac surgery with use of cardiopulmonary bypass support initiates a systemic inflammatory response presumably caused by contact of blood components with the artificial surface of the extracorporeal circuit, associated with postoperative morbidity and mortality [22, 24, 25]. In this regard, many studies demonstrated increased inflammatory markers, such as TNF-α, IL-6, IL-8 after cardiac surgery with cardiopulmonary bypass (CPB) inducing organ failure [26]. Massive activation of leukocytes, e.g. neutrophils, and different biochemical pathways may result in microthrombosis, microemboli and depletion of coagulation factors [22]. These factors contribute to tissue injury and endothelial dysfunction, to predisposing patients to organ injury and to increasing perivascular edema [22, 27]. Renal dysfunction can be a common complication after coronary artery bypass surgery with use of heart-lung machine [4, 9]. The inflammatory reaction is induced by use of the heart-lung machine. Some studies revealed a correlation in terms of duration of heart-lung machine with kidney injury [22]. One aim of this study was to evaluate early outcomes with respect to renal function comparing OPCAB with on-pump surgery. Studies revealed controversial results in this field [1, 28, 29]. It has been speculated that coronary artery bypass surgery without use of extracorporeal circulation might positively influence incidence and seriousness of acute renal failure [30]. Li et al. described an incidence of AKI of 37.1% after off-pump surgery [31]. Our study reported similar rates of occurrence of renal failure between groups, confirming the findings of other trials showing that off-pump surgery is not associated with decreased rates or reduced severity of acute renal failure [10, 11]. We also found that impairment of renal function did not differ between groups. Singh et al. measured creatinine up to 4 days postoperatively and the results were similar compared with preoperative levels. They found no statistically significant rise in creatinine in either of the two groups corroborating our results [32]. Thus, they concluded that renal function is not affected by the technique of coronary artery bypass surgery whether with or without cardiopulmonary bypass in spite of the theoretical expected advantage of off-pump surgery [32].

Medved et al. also found no difference in postoperative creatine kinase MB after first day and stay on ICU corroborating our results [20]. Additionally, they revealed similar results in early mortality, whereas we found of a 1.5-fold higher risk for OPCAB group in long-term follow-up (HR = 1.50; p = 0.066) without reaching significance between groups. Also Kaplan-Meier estimation analysis showed similar results between groups (Log-Rank p = 0.064). In our study the number of grafts was similar to the results by Lycops et al. [19]. Interestingly, in terms of 5-year survival Lycops et al. revealed 78% in OPCAB group and 68% in on-pump group, whereas we found a 7-year follow-up survival rate of 81% in OPCAB surgery and 89% in on-pump group. Also, Nicolini et al. found out that on-pump surgery is associated with a lower 5-year mortality than OPCAB group corroborating our results [4]. They also found no differences in terms of incidence of myocardial infarction or stroke affirming our findings. Additionally preoperative statin use does not influence development of postoperative AKI [33].

Conclusion

Regarding postoperative renal impairment we did not find any differences between patients’ groups undergoing off- or on-pump surgery. Also, odds of early outcomes were similar in both groups as well as incidence of myocardial infarction and mortality in long-term follow-up.

Study limitations

This study is limited by its retrospective nature, heterogeneity of patient population and relatively small number of patients from a single hospital center. Also, the retrospective nature of this study may introduce confounders and bias of patient selection.

Supporting information

S1 Data [sav]
Data set of variables of patients undergoing coronary artery bypass surgery with and without use of heart-lung machine.


Zdroje

1. Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(4):797–808. doi: 10.1067/mtc.2003.324 12698142

2. Sedrakyan A, Wu AW, Parashar A, Bass EB, Treasure T. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials. Stroke. 2006;37(11):2759–69. doi: 10.1161/01.STR.0000245081.52877.f2 17008617

3. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Straka Z, et al. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. N Engl J Med. 2016;375(24):2359–68. doi: 10.1056/NEJMoa1601564 27771985

4. Nicolini F, Fortuna D, Contini GA, Pacini D, Gabbieri D, Zussa C, et al. Comparison between off- and on-pump coronary artery bypass grafting: long-term results of a real-world registry. Eur J Cardiothorac Surg. 2016;50(3):528–35. doi: 10.1093/ejcts/ezw128 27118313

5. Staton GW, Williams WH, Mahoney EM, Hu J, Chu H, Duke PG, et al. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest. 2005;127(3):892–901. doi: 10.1378/chest.127.3.892 15764773

6. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004;291(15):1841–9. doi: 10.1001/jama.291.15.1841 15100202

7. Takagi H, Tanabashi T, Kawai N, Umemoto T. Off-pump surgery does not reduce stroke, compared with results of on-pump coronary artery bypass grafting: a meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2007;134(4):1059–60. doi: 10.1016/j.jtcvs.2007.07.006 17903537

8. Bakaeen FG, Chu D, Kelly RF, Ward HB, Jessen ME, Chen GJ, et al. Performing coronary artery bypass grafting off-pump may compromise long-term survival in a veteran population. Ann Thorac Surg. 2013;95(6):1952–8; discussion 9–60. doi: 10.1016/j.athoracsur.2013.02.064 23647861

9. Wang Y, Zhu S, Gao P, Zhou J, Zhang Q. Off-pump versus on-pump coronary surgery in patients with chronic kidney disease: a meta-analysis. Clin Exp Nephrol. 2018;22(1):99–109. doi: 10.1007/s10157-017-1432-7 28634771

10. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368(13):1179–88. doi: 10.1056/NEJMoa1301228 23477676

11. Diegeler A, Reents W, Zacher M. Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med. 2013;369(2):196–7.

12. Houlind K, Fenger-Gron M, Holme SJ, Kjeldsen BJ, Madsen SN, Rasmussen BS, et al. Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: results from the Danish On-pump Versus Off-pump Randomization Study (DOORS). J Thorac Cardiovasc Surg. 2014;148(5):1812–9 e2. doi: 10.1016/j.jtcvs.2014.02.024 24613160

13. Magee MJ, Coombs LP, Peterson ED, Mack MJ. Patient selection and current practice strategy for off-pump coronary artery bypass surgery. Circulation. 2003;108 Suppl 1:II9–14.

14. Spina S, Lei C, Pinciroli R, Berra L. Hemolysis and Kidney Injury in Cardiac Surgery: The Protective Role of Nitric Oxide Therapy. Semin Nephrol. 2019;39(5):484–95. doi: 10.1016/j.semnephrol.2019.06.008 31514912

15. Zaouter C, Potvin J, Bats ML, Beauvieux MC, Remy A, Ouattara A. A combined approach for the early recognition of acute kidney injury after adult cardiac surgery. Anaesth Crit Care Pain Med. 2018;37(4):335–41. doi: 10.1016/j.accpm.2018.05.001 29777769

16. Boyd WD, Desai ND, Del Rizzo DF, Novick RJ, McKenzie FN, Menkis AH. Off-pump surgery decreases postoperative complications and resource utilization in the elderly. Ann Thorac Surg. 1999;68(4):1490–3. doi: 10.1016/s0003-4975(99)00951-0 10543551

17. Kim HJ, Chung JE, Jung JS, Kim IS, Son HS. Current Status of Off-pump Coronary Artery Bypass Grafting in Patients with Multiple Coronary Artery Disease Compared with On-pump Coronary Artery Bypass Grafting: The Korean National Cohort Study. Thorac Cardiovasc Surg. 2018;66(6):470–6. doi: 10.1055/s-0038-1651516 29852507

18. Dai Z, Chu H, Wang S, Liang Y. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: A systematic review and cumulative meta-analysis. J Clin Anesth. 2018;44:23–31. doi: 10.1016/j.jclinane.2017.10.004 29107853

19. Lycops A, Wever C, Vandekerkhof J, Mees U, Hendrikx M. Midterm follow-up after off-pump versus on-pump coronary artery bypass grafting. Results from a case-matched study. Acta Cardiol. 2005;60(3):311–7. doi: 10.2143/AC.60.3.2005010 15999472

20. Medved I, Anic D, Zrnic B, Ostric M, Saftic I. Off-pump versus on-pump—intermittent aortic cross clamping—myocardial revascularisation: single center expirience. Coll Antropol. 2008;32(2):381–4. 18756885

21. Fortuna D, Nicolini F, Guastaroba P, De Palma R, Di Bartolomeo S, Saia F, et al. Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: a comparative effectiveness study based on propensity score-matched cohorts. Eur J Cardiothorac Surg. 2013;44(1):e16–24. doi: 10.1093/ejcts/ezt197 23628951

22. Paunel-Gorgulu A, Wacker M, El Aita M, Hassan S, Schlachtenberger G, Deppe A, et al. cfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9-independent manner. Sci Rep. 2017;7(1):17421. doi: 10.1038/s41598-017-17561-1 29234042

23. Merkle J, Daka A, Deppe AC, Wahlers T, Paunel-Gorgulu A. High levels of cell-free DNA accurately predict late acute kidney injury in patients after cardiac surgery. PLoS One. 2019;14(6):e0218548. doi: 10.1371/journal.pone.0218548 31211810

24. Caputo M, Mokhtari A, Miceli A, Ghorbel MT, Angelini GD, Parry AJ, et al. Controlled reoxygenation during cardiopulmonary bypass decreases markers of organ damage, inflammation, and oxidative stress in single-ventricle patients undergoing pediatric heart surgery. J Thorac Cardiovasc Surg. 2014;148(3):792–801 e8; discussion 0–1. doi: 10.1016/j.jtcvs.2014.06.001 25052821

25. Li Z, Fan G, Zheng X, Gong X, Chen T, Liu X, et al. Risk factors and clinical significance of acute kidney injury after on-pump or off-pump coronary artery bypass grafting: a propensity score-matched study. Interact Cardiovasc Thorac Surg. 2019;28(6):893–9. doi: 10.1093/icvts/ivy353 30649484

26. Sander M, von Heymann C, von Dossow V, Spaethe C, Konertz WF, Jain U, et al. Increased interleukin-6 after cardiac surgery predicts infection. Anesth Analg. 2006;102(6):1623–9. doi: 10.1213/01.ane.0000215998.21739.48 16717298

27. Amini S, Najafi MN, Karrari SP, Mashhadi ME, Mirzaei S, Tashnizi MA, et al. Risk Factors and Outcome of Acute Kidney Injury after Isolated CABG Surgery: a Prospective Cohort Study. Braz J Cardiovasc Surg. 2019;34(1):70–5. doi: 10.21470/1678-9741-2017-0209 30810677

28. Puskas JD, Kilgo PD, Lattouf OM, Thourani VH, Cooper WA, Vassiliades TA, et al. Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann Thorac Surg. 2008;86(4):1139–46; discussion 46. doi: 10.1016/j.athoracsur.2008.05.073 18805149

29. Chu D, Bakaeen FG, Dao TK, LeMaire SA, Coselli JS, Huh J. On-pump versus off-pump coronary artery bypass grafting in a cohort of 63,000 patients. Ann Thorac Surg. 2009;87(6):1820–6; discussion 6–7. doi: 10.1016/j.athoracsur.2009.03.052 19463602

30. Bucerius J, Gummert JF, Walther T, Borger MA, Doll N, Falk V, et al. Impact of off-pump coronary bypass grafting on the prevalence of adverse perioperative outcome in women undergoing coronary artery bypass grafting surgery. Ann Thorac Surg. 2005;79(3):807–12; discussion 12–3. doi: 10.1016/j.athoracsur.2004.06.013 15734382

31. Li XH, Xiao F, Zhang SY. [Investigation of risk factors of acute kidney injury after off-pump coronary artery bypass grafting and 3 years' follow-up]. Beijing Da Xue Xue Bao Yi Xue Ban. 2017;49(1):131–6. 28203019

32. Singh RS, Thingnam SKS, Mishra AK, Verma I, Kumar V. Renal function after off-pump versus on-pump coronary artery bypass grafting. Asian Cardiovasc Thorac Ann. 2017;25(7–8):504–8. doi: 10.1177/0218492317730256 28847152

33. Park J, Lee JH, Kim KA, Lee SH, Lee YT, Kim WS, et al. Effects of Preoperative Statin on Acute Kidney Injury After Off-Pump Coronary Artery Bypass Grafting. J Am Heart Assoc. 2019;8(7):e010892. doi: 10.1161/JAHA.118.010892 30905260


Článok vyšiel v časopise

PLOS One


2019 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#